Stay updated on Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a 2016 ( U.S. NIH Grant/Contract ) note to the study identifiers. Updated the site revision label to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T21:51:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.4 to v3.6.5, indicating an updated version of the page. This is a metadata update rather than a modification to study content or functionality.
    Difference
    0.1%
    Check dated 2026-08-08T20:45:33.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page. No substantive changes to study details are evident.
    Difference
    0.1%
    Check dated 2026-07-25T13:23:12.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a new site release version for the page, likely a minor update to metadata or rendering.
    Difference
    0.1%
    Check dated 2026-07-04T03:51:15.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page footer revision tag changed from v3.6.0 to v3.6.2, reflecting a newer site build.
    Difference
    0.1%
    Check dated 2026-06-26T23:07:38.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The study page adds new metadata and help sections and updates the author label to Prof. Silvia Novello. It standardizes the Intervention/Treatment heading and increases the page revision to v3.6.0.
    Difference
    1%
    Check dated 2026-06-12T16:43:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.